The company provides a range of specialty biochemicals, drug discovery kits, bulk enzymes, and substrates for inhibitor screening of therapeutic targets, as well as compound libraries for receptor de-orphaning, assay development, and chemical genomics. Its products are used in various areas such as signal transduction, lipid signaling, post translational modifications, proteolysis, ubiquitons and zomes, and neuroscience. BIOMOL International, LP also offers custom services for drug discovery programs and distributes its products globally through an online catalog and distributors in various regions. The company was founded in 1983 and is based in Plymouth Meeting, Pennsylvania, with production facilities in the Greater Philadelphia region and Exeter, the United Kingdom.